APOTHEEK KESTELYN: what changed
What changed
APOTHEEK KESTELYN
NACE 47.730, Retail sale of pharmaceutical products
filed annual accounts (NBB)
Net result for the year
€171,088
2025 · €206,393-€35,305
Equity
€424,627
2025 · €423,539+€1,088
Cash
€361,889
2025 · €390,065-€28,176
Balance sheet total
€1.9m
2025 · €1.9m-€19,437
Largest movements
Assets
- Tangible fixed assets -€48,998
down €48,998 (-5.7%), from €857,578 to €808,580
of which Plant, machinery and equipment: -€35,813
- Stocks and contracts +€43,500
up €43,500 (+13.9%), from €312,289 to €355,788
- Cash -€28,176
down €28,176 (-7.2%), from €390,065 to €361,889
mainly Contributions, distributions and other (-€170,000) and Stocks and contracts (-€43,500)
Equity and liabilities
- Current portion of long-term debt -€25,653
down €25,653 (-55.6%), from €46,112 to €20,458
Income statement
- Gross operating margin -€38,724
down €38,724 (-7.2%), from €534,123 to €495,399
- Depreciation -€12,727
down €12,727 (-13.9%), from €91,313 to €78,586
- Financial income -€5,442
down €5,442 (-61.6%), from €8,839 to €3,398
Change in the result, 2025 to 2026
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Result 2025
€206,393
Gross operating margin
-€38,724
Staff costs
-€82
Depreciation
+€12,727
Other operating charges
+€842
Other operating items
-€1,082
Financial income
-€5,442
Financial charges
-€3,112
Taxes
-€433
Result 2026
€171,088
raises the resultlowers the resultnot broken down further in the accounts
Derived cash bridge
The bridge is derived from the 2025 and 2026 balance sheets and the 2026 result. There is no filed cash-flow statement. You see where the money came from and where it went.
From operations
+€212,337
Investment
-€29,587
Financing
-€210,926
Cash 2025
€390,065
From operations (derived)
+€212,337
Net result for the year
+€171,088
Depreciation
+€78,586
Stocks and contracts
-€43,500
Receivables within one year
-€17,041
Deferred charges and accrued income
+€2,803
Trade debts
+€8,220
Tax, wage and social debts
-€957
Advances received
+€4,529
Other debts
+€8,979
Accrued charges and deferred income
-€371
Investment (derived)
-€29,587
Investment in fixed assets (net)
-€29,587
Financing
-€210,926
Debts after one year
-€15,273
Current portion of long-term debt
-€25,653
Contributions, distributions and other
-€170,000
Cash 2026
€361,889
brings cash intakes cash out
Every line side by side
| Line | Code | 2025 | 2026 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,880,359 | €1,860,922 | -€19,437 | -1.0% |
| Fixed assets | 21/28 | €968,689 | €919,691 | -€48,998 | -5.1% |
| Tangible fixed assets | 22/27 | €857,578 | €808,580 | -€48,998 | -5.7% |
| Land and buildings | 22 | €519,616 | €504,381 | -€15,236 | -2.9% |
| Plant, machinery and equipment | 23 | €319,059 | €283,246 | -€35,813 | -11.2% |
| Furniture and vehicles | 24 | €5,988 | €9,404 | +€3,415 | +57.0% |
| Other tangible fixed assets | 26 | €12,915 | €11,550 | -€1,365 | -10.6% |
| Assets under construction and advance payments | 27 | €0 | - | = | |
| Financial fixed assets | 28 | €111,111 | €111,111 | = | 0.0% |
| Current assets | 29/58 | €911,670 | €941,231 | +€29,562 | +3.2% |
| Stocks and contracts in progress | 3 | €312,289 | €355,788 | +€43,500 | +13.9% |
| Stocks | 30/36 | €312,289 | €355,788 | +€43,500 | +13.9% |
| Amounts receivable within one year | 40/41 | €169,649 | €186,691 | +€17,041 | +10.0% |
| Trade receivables | 40 | €150,611 | €174,081 | +€23,469 | +15.6% |
| Other amounts receivable | 41 | €19,038 | €12,610 | -€6,428 | -33.8% |
| Cash at bank and in hand | 54/58 | €390,065 | €361,889 | -€28,176 | -7.2% |
| Deferred charges and accrued income | 490/1 | €39,666 | €36,863 | -€2,803 | -7.1% |
| Total equity and liabilities | 10/49 | €1,880,359 | €1,860,922 | -€19,437 | -1.0% |
| Equity | 10/15 | €423,539 | €424,627 | +€1,088 | +0.3% |
| Contributions | 10/11 | €62,000 | €62,000 | = | 0.0% |
| Capital | 10 | €62,000 | €62,000 | = | 0.0% |
| Issued capital | 100 | €62,000 | €62,000 | = | 0.0% |
| Reserves | 13 | €361,539 | €362,627 | +€1,088 | +0.3% |
| Non-distributable reserves | 130/1 | €6,200 | €6,200 | = | 0.0% |
| Legal reserve | 130 | €6,200 | €6,200 | = | 0.0% |
| Tax-exempt reserves | 132 | €885 | €885 | = | 0.0% |
| Distributable reserves | 133 | €354,454 | €355,542 | +€1,088 | +0.3% |
| Profit (loss) carried forward | 14 | €0 | €0 | = | |
| Amounts payable | 17/49 | €1,456,820 | €1,436,295 | -€20,525 | -1.4% |
| Amounts payable after more than one year | 17 | €252,906 | €237,634 | -€15,273 | -6.0% |
| Financial debts | 170/4 | €252,906 | €237,634 | -€15,273 | -6.0% |
| Amounts payable within one year | 42/48 | €1,203,291 | €1,198,410 | -€4,881 | -0.4% |
| Current portion of amounts payable after more than one year | 42 | €46,112 | €20,458 | -€25,653 | -55.6% |
| Trade debts | 44 | €85,379 | €93,599 | +€8,220 | +9.6% |
| Suppliers | 440/4 | €85,379 | €93,599 | +€8,220 | +9.6% |
| Advances received on contracts in progress | 46 | - | €4,529 | +€4,529 | |
| Taxes, remuneration and social security | 45 | €37,842 | €36,885 | -€957 | -2.5% |
| Taxes | 450/3 | €2,261 | €1,191 | -€1,070 | -47.3% |
| Remuneration and social security | 454/9 | €35,582 | €35,695 | +€113 | +0.3% |
| Other amounts payable | 47/48 | €1,033,958 | €1,042,937 | +€8,979 | +0.9% |
| Accrued charges and deferred income | 492/3 | €623 | €252 | -€371 | -59.5% |
| Non-recurring operating income | 76A | €65,500 | €0 | -€65,500 | -100% |
| Remuneration, social security and pensions | 62 | €200,987 | €201,069 | +€82 | 0.0% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €91,313 | €78,586 | -€12,727 | -13.9% |
| Other operating charges | 640/8 | €2,164 | €1,321 | -€842 | -38.9% |
| Non-recurring operating charges | 66A | €0 | €1,082 | +€1,082 | |
| Gross operating margin | 9900 | €534,123 | €495,399 | -€38,724 | -7.2% |
| Operating profit (loss) | 9901 | €239,659 | €213,341 | -€26,318 | -11.0% |
| Financial income | 75/76B | €8,839 | €3,398 | -€5,442 | -61.6% |
| Recurring financial income | 75 | €8,839 | €3,398 | -€5,442 | -61.6% |
| Financial charges | 65/66B | €41,662 | €44,774 | +€3,112 | +7.5% |
| Recurring financial charges | 65 | €41,662 | €44,774 | +€3,112 | +7.5% |
| Profit (loss) for the period before taxes | 9903 | €206,837 | €171,965 | -€34,872 | -16.9% |
| Income taxes | 67/77 | €444 | €877 | +€433 | +97.6% |
| Profit (loss) for the period | 9904 | €206,393 | €171,088 | -€35,305 | -17.1% |
| Profit (loss) for the period to be appropriated | 9905 | €206,393 | €171,088 | -€35,305 | -17.1% |
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Compare this company with its sector.Sector benchmark
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 March 2025 and 31 March 2026. Green is a favourable move for that line, red an unfavourable one. Prepared on 6 November 2026 via checked.be.